LFCR insider trading
NasdaqGS HealthcareLIFECORE BIOMEDICAL, INC. \DE\ — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About LIFECORE BIOMEDICAL, INC. \DE\
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It offers services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Company website: www.lifecore.com
LFCR insider activity at a glance
FilingIQ has scored 92 insider transactions for LFCR since Nov 25, 2022. The most recent filing in our index is dated Apr 14, 2026.
Across the full history, 9 open-market purchases
and 10 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on LFCR insider trades is 56.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest LFCR Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
13F funds holding LFCR
Frequently asked
- How many insider trades does FilingIQ track for LFCR?
- FilingIQ tracks 92 Form 4 insider transactions for LFCR (LIFECORE BIOMEDICAL, INC. \DE\), covering filings from Nov 25, 2022 onwards. 2 of those were filed in the last 90 days.
- Are LFCR insiders net buyers or net sellers?
- Across the full Form 4 history for LFCR, 9 transactions (10%) were open-market purchases and 10 (11%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does LFCR insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is LFCR in?
- LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $263.01M.
Methodology & sources
Every LFCR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.